

Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative.
Investor Presentation Deck
Tetra Investor Presentation


Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative.
Investor Presentation Deck
Tetra Investor Presentation
VANCOUVER, Washington, Oct. 01, 2019– CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today FDA clearance […]
Beckerman will represent Elixinol’s position in hemp industry’s dynamic U.S. regulatory and advocacy environment DENVER , Jan 03, 2019 — Elixinol, a wholly owned subsidiary of Elixinol Global (EXL) (asx:EXL) announces Joy Beckerman’s appointment to Elixinol’s […]
VANCOUVER, British Columbia, April 09, 2019 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE: BOSS) (OTC: BOSQF) (frankfurt:YG3) announces its subsidiary Urban Juve has received positive national media attention from two of Canada’s leading lifestyle magazines […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
